WaKING: Wnt and checKpoint INhibition in Gastric Cancer
NCT04166721
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
52
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Esophageal Cancer
Metastatic Gastric Cancer
Interventions
DRUG:
Atezolizumab
Sponsor
Royal Marsden NHS Foundation Trust